V. Pallarés-Carratalá

Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion Study

V. Barrios, V. Pallarés-Carratalá, S. Cinza-Sanjurjo, 2023, International journal of environmental research and public health.

Vitamin D Supplementation and Its Impact on Mortality and Cardiovascular Outcomes: Systematic Review and Meta-Analysis of 80 Randomized Clinical Trials

J. Martin-Moreno, Ferran Torres, V. Pallarés-Carratalá, 2023, Nutrients.

Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study

J. A. Divisón-Garrote, V. Pallarés-Carratalá, C. Escobar-Cervantes, 2023, Medicina.

Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review.

M. Prieto-Díaz, J. A. Divisón-Garrote, V. Pallarés-Carratalá, 2022, Semergen.

Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular–Kidney–Metabolic Factors: SIMETAP-AF Study

A. Serrano-Cumplido, Ezequiel Arranz-Martínez, Carlos Escobar-Cervantes, 2024, Medicina.

Hyperuricaemia Prevalence Rates According to Their Physiochemical and Epidemiological Diagnostic Criteria and Their Associations with Cardio-Renal-Metabolic Factors: SIMETAP-HU Study

C. Escobar-Cervantes, A. Serrano-Cumplido, Ezequiel Arranz-Martínez, 2024, Journal of clinical medicine.

Heart Failure Prevalence Rates and Its Association with Other Cardiovascular Diseases and Chronic Kidney Disease: SIMETAP-HF Study

V. Pallarés-Carratalá, C. Escobar-Cervantes, A. Ruiz-García, 2023, Journal of clinical medicine.

[Clinical and practical management of sodium-glucose cotransporter type 2 inhibitors in patients with chronic kidney disease].

M. Turégano-Yedro, M. Castillo Moraga, V. Pallarés-Carratalá, 2023, Semergen.